http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-109700858-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationIPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K125-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-704 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4196 |
| filingDate | 2019-03-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2021-11-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2021-11-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-109700858-B |
| titleOfInvention | Application of gynura segetum in preparing antifungal medicine and synergist thereof |
| abstract | The invention discloses application of gynura segetum in preparing antifungal medicines and a synergist thereof, and belongs to the technical field of medicines. In vitro cell experiments show that the panax notoginseng has different degrees of antifungal and even antifungal effects on the panax notoginseng against drug-resistant candida albicans 103, sensitive candida albicans SC5314, cryptococcus neoformans 32609, natural drug-resistant candida krusei ATCC2340, candida parapsilosis 22019, natural drug-resistant candida glabrata ATCC2281 and drug-resistant candida tropicalis, so that the panax notoginseng can be used as an antifungal drug and a synergist thereof. The invention opens up a new application of the gynura segetum, and provides a new candidate drug for preparing antifungal drugs and treating fungal infection. |
| priorityDate | 2019-03-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 18.